COVID-19
During the Coronavirus Disease 2019 (COVID-19) pandemic, the concerns of congenital heart defect patients and their relatives evolved significantly, with a shift from fear and uncertainty to vaccination-related concerns. A nationwide online survey conducted by the German National Register for Congenital Heart Defects (NRCHD) in April 2020 and April 2021
COVID-19
Research conducted by a team of scientists at Shanxi Agricultural University has led to the development of a trispecific fusion protein that targets COVID-19 with promising results. The study focused on the severe consequences of COVID-19 infections, particularly among elderly individuals and those with underlying medical conditions. The research identified
Coronaviruses
A recent study conducted by researchers at Ahvaz Jundishapur University of Medical Sciences, in collaboration with international experts, has shed new light on the role of microRNAs (miRNAs) in the diagnosis and management of COVID-19. The study analyzed the expression levels of miR200b-3p, miR34b-5p, miR203a-3p, and Let7g-5p in the blood
Coronaviruses
Research from NOVA Southeastern University sheds light on the ongoing effects of COVID-19, particularly the lingering symptoms that persist even after recovery. Scientists analyzed the current literature on long-term manifestations of COVID-19 and observed a range of symptoms, including fatigue, brain fog, respiratory difficulties, and loss of taste and smell.
Coronaviruses
Researchers from Yale University School of Medicine and the Centers for Disease Control and Prevention (CDC) published a study in Clinical Infectious Diseases, examining the impact of repeated SARS-CoV-2 infections on long-term clinical outcomes. The study found that repeated infection with Omicron variants may increase the risk of long-term symptoms,
Brain
Prolonged effects of COVID-19 infection have been observed in many individuals, with a significant proportion experiencing persistent neuropsychological symptoms, including brain fog. A recent study has shed light on these symptoms, highlighting the importance of addressing the biopsychosocial components of post-acute COVID-19 syndrome (PACS). Researchers from the Institute for Rehabilitation
Clinical trials
Researchers at the Department of Research, led by Gitanjali Talele, have published a study investigating the safety, efficacy, and immunogenicity of an oral homeopathic SARS-CoV-2 nosode, BiosimCovex, in preventing COVID-19 infection. The phase III, multicentre, randomized, double-blind, placebo-controlled trial involved 2671 unvaccinated participants from 13 sites in India. Participants received
Coronaviruses
Researchers from Wroclaw Medical University in Poland have published a study on the attitudes of parents towards vaccinating their children against COVID-19. The study, conducted in 2025, aimed to understand the reasons behind parents' distrust of the vaccination program, particularly in regards to children. The research found that over
Antigenic determinants
Researchers have developed a new approach to vaccine design that could provide effective protection against both Influenza A Virus and SARS-CoV-2. The study, published in Human Immunology, employed a bioinformatic approach to design a hybrid vaccine based on the epitopes of both viruses. This innovative method has the potential to
Coronaviruses
A recent study conducted in Qatar has shed light on the effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection. The research, published in the journal Scientific Reports, found that the fourth dose conferred modest additional protection against infection, with an adjusted hazard ratio for
Communicable diseases
As the global community grapples with the persistence of the SARS-CoV-2 virus, a new study from Quzhou, People's Republic of China, sheds light on the efficacy of existing COVID-19 vaccines in older adults. The research, published in Signal Transduction and Targeted Therapy, reveals that while XBB-containing vaccine-induced immunity
Coronaviruses
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery in the fight against COVID-19. By analyzing Germinal center B cell responses in nine healthy adults after mRNA booster immunization, they found that 77.8% of the B cell clones in the Germinal center expressed
